Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue SUPPL. 3, 2012, Pages 11-21

  Archier, E ^a   Devaux, S ^b   Castela, E ^c   Gallini, A ^d   Aubin, F ^e   Le Maitre M ^f   Aractingi, S ^g   Bachelez, H ^h   Cribier, B ⁱ   Joly, P ^j   Jullien, D ^k   Misery, L ^l   Paul, C ^b   Ortonne, J P ^c   Richard, M A ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d Faculté de Médecine Centre Hospitalo universitaire   (France)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

^f Saint Louis Hospital ^*

^g HÔPITAL TENON   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^j UNIVERSITÉ DE ROUEN   (France)

^k EDOUARD HERRIOT HOSPITAL   (France)

^l BREST UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; CALCIPOTRIOL; COAL TAR; DITHRANOL; ETRETIN; ETRETINATE; METHOTREXATE; METHOXSALEN; PLACEBO; RETINOID;

CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DRUG EFFICACY; HUMAN; MEDICAL LITERATURE; PREDICTIVE VALUE; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION DOSE; REVIEW; SYSTEMATIC REVIEW; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

CHRONIC DISEASE; HUMANS; METHOXSALEN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSORIASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ULTRAVIOLET RAYS;

EID: 84860196312     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04519.x     Document Type: Review

References (39)

1. Davidovici BB, Sattar N, Jorg PC, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-1796.
2. Parrish JA, Fitzpatrick TB, Tanenbaum L, et al. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974; 291: 1207-1211.
3. van Weelden H, van der Leun JC,. Improving the effectiveness of phototherapy for psoriasis [abstract]. Br J Dermatol 1984; 111: 484.
4. van der Leun JC, vanWeelden H,. UV-B phototherapy: principles, radiation sources, regimens. Curr Probl Dermatol 1986; 15: 39-51.
5. Paul C, Gallini A, Archier E, et al. Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. JEADV 2012; 26 (Suppl. 3): 1-10.
6. Evers AW, Kleinpenning MM, Smits T, et al. Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy. Br J Dermatol 2009; 161: 542-546.
7. Kleinpenning MM, Smits T, Boezeman J, et al. Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens. Br J Dermatol 2009; 161: 1351-1356.
8. Altiner DD, Ilknur T, Fetil E, et al. Comparison of weekly and daily incremental protocols of narrowband ultraviolet B phototherapy for psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 1076-1080. (Pubitemid 44425963)
9. Cameron H, Dawe RS, Yule S, et al. A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol 2002; 147: 973-978. (Pubitemid 35365446)
10. Dawe RS, Wainwright NJ, Cameron H, et al. Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol 1998; 138: 833-839. (Pubitemid 28231525)
11. Dawe RS, Cameron HM, Yule S, et al. A randomized comparison of methods of selecting narrowband uv-b starting dose to treat chronic psoriasis. Arch Dermatol 2011; 147: 168-174.
12. Jacobe H, Winterfield L, Kim F, et al. The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis. Arch Dermatol 2008; 144: 1067-1068; author reply 1068-9.
13. Kirke SM, Lowder S, Lloyd JJ, et al. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis. J Invest Dermatol 2007; 127: 1641-1646. (Pubitemid 46933429)
14. Grundmann-Kollmann M, Ludwig R, Zollner TM, et al. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis. J Am Acad Dermatol 2004; 50: 734-739. (Pubitemid 38580552)
15. Swinkels OQJ, Prins M, Veenhuis RT, et al. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis. Eur J Dermatol 2004; 14: 159-165. (Pubitemid 38738455)
16. Mahajan R, Kaur I, Kanwar AJ, et al. Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis-a randomized single-blinded placebo-controlled study. J Eur Acad Dermatol Venereol 2010; 24: 595-600.
17. Bagel J,. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone. J Drugs Dermatol 2009; 8: 351-357.
18. Selvaag E, Caspersen L, Bech-Thomsen N, et al. Optimized UVB treatment of psoriasis: a controlled, left-right comparison trial. J Eur Acad Dermatol Venereol 2000; 14: 19-21. (Pubitemid 32899316)
19. Wainwright NJ, Dawe RS, Ferguson J, et al. Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen? Br J Dermatol 1998; 139: 410-414. (Pubitemid 28430456)
20. Hofer A, Fink-Puches R, Kerl H, et al. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol 1998; 138: 96-100. (Pubitemid 28077944)
21. Léauté-Labrèze C, Saillour F, Chêne G, et al. Saline spa water or combined water and UV-B for psoriasis vs. conventional UV-B. Lessons from the salies de béarn randomized study. Arch Dermatol 2001; 137: 1035-1039. (Pubitemid 32756461)
22. Brands S, Brakman M, Bos JD, et al. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. J Am Acad Dermatol 1999; 41: 991-995.
23. Lowe NJ, Prystowsky JH, Bourget T, et al. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol 1991; 24: 591-594.
24. Collins P, Wainwright NJ, Amorim I., et al. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach. Br J Dermatol. 1996; 135: 248-254. (Pubitemid 26252974)
25. Buckley DA, Healy E, Rogers S, et al. A comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis. Br J Dermatol 1995; 133: 417-422.
26. Kirby B, Buckley DA, Rogers S, et al. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis. Br J Dermatol 1999; 140: 661-666. (Pubitemid 29191385)
27. Valbuena MC, Hernandez O, Rey M, et al. Twice- vs. thrice-weekly MPD PUVA in psoriasis: a randomized-controlled efficacy study. Photodermatol Photoimmunol Photomed 2007; 23: 126-129. (Pubitemid 47034528)
28. Lauharanta J, Juvakoski T, Lassus A, et al. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis. Br J Dermatol 1981; 104: 325-332. (Pubitemid 11060745)
29. Sivanesan SP, Gattu S, Hong J, et al. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks. J Am Acad Dermatol 2009; 61: 793-798.
30. Legat FJ, Hofer A, Quehenberger F, et al. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA. J Am Acad Dermatol 2004; 51: 746-754. (Pubitemid 39516889)
31. Cooper EJ, Herd RM, Priestley GC, Hunter JA,. A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis. Clin Exp Dermatol 2000; 25: 111-114. (Pubitemid 30212416)
32. Yones SS, Palmer RA, Garibaldinos TT, et al. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy. Arch Dermatol 2006; 142: 836-842. (Pubitemid 44079782)
33. Markham T, Rogers S, Collins P, et al. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol 2003; 139: 325-328. (Pubitemid 36330579)
34. Gordon PM, Diffey BL, Matthews JN, et al. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41: 728-732. (Pubitemid 29514028)
35. Schmutz JL, Jeanmougin M, Martin S, et al. Recommandations de la société française de photodermatologie pour la PUVAthérapie systémique dans le psoriasis vulgaire. Ann Dermatol Venereol 2000; 127: 73-79.
36. Beani JC, Jeanmougin M,. La photothérapie UVB à spectre étroit dans le psoriasis vulgaire: utilisation pratique et préconisations de la société française de photodermatologie. Ann Dermatol Venereol 2010; 137: 21-31.
37. Ibbotson SH, Bilsland D, Cox NH, et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004; 151: 283-297. (Pubitemid 39215142)
38. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 2010; 62: 114-135.
39. E Archier, S Devaux, E Castela, et al. Carcinogenic risks of Psoralen UV-A Therapy and Narrowband UV-B Therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26 (Suppl. 3): 22-31.